Public, private investors must fill the void left by venture capitalists

01/10/2013 | Xconomy

Venture capitalists have proven more willing to invest in health care-related software applications than in early-stage medical research, which carries more risk and longer times to return on investment, writes consultant Stewart Lyman. Alliances between Big Pharma and academic institutions, patient group investment units, public funding for research, tax breaks and prizes help encourage research. "Fighting disease isn’t just a good investment in our health; it’s also an excellent investment in our economy," Lyman writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY